中銀香港(2388.HK)跌超5% 2020年淨利潤減少17.7%
格隆匯3月31日丨中銀香港(2388.HK)盤中大跌,一度跌5.1%報27港元,市值2862億港元。公司昨晚公佈業績顯示,2020年溢利284.68億港幣,按年回落16.5%;股東應占溢利264.87億港元,同比減少17.7%;每股基本盈利2.5052港幣;每股股息為1.2420港幣,派息比率為49.6%。公吿稱,年內宏觀經濟前景轉差,導致減值準備淨撥備按年增加。投資物業公平值調整錄得淨虧損,上年為淨收益。提取減值準備前之淨經營收入為港幣544.74億元,按年減少6.8%,主要由於市場利率下降,淨利息收入按年下降。受新冠肺炎疫情及經濟下行影響,淨服務費及佣金收入輕微下降。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.